U.S. Gas Utilities Stock News

NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Faster Revenue Growth With Wider Losses Might Change The Case For Investing In Axsome (AXSM)

Axsome Therapeutics, Inc. recently reported second-quarter 2026 results, with revenue rising to US$218.38 million from US$150.04 million a year earlier, while net loss widened to US$51.31 million and basic loss per share from continuing operations was US$0.99. Despite strong year-over-year revenue growth across both the quarter and first half of 2026, Axsome’s net losses and loss per share both increased, underscoring the cost of its expanding CNS portfolio and commercialization efforts. We...
NasdaqGS:LQDT
NasdaqGS:LQDTCommercial Services

Liquidity Services (LQDT) Gains On Strong Results But Is The Valuation Already Priced In

Why Liquidity Services Stock Is Back On Investor Radars Liquidity Services (LQDT) has drawn fresh attention after reporting third quarter and nine month results to June 30, 2026, alongside new guidance for the upcoming quarter that outlines expected net income and earnings per share. See our latest analysis for Liquidity Services. The latest results and guidance appear to have fed into a strong run for Liquidity Services, with the share price at $40.91 and a 90 day share price return of...
NYSE:WMB
NYSE:WMBOil and Gas

How Investors May Respond To Williams (WMB) Earnings Beat, Dividend Hike and Big-Ticket Growth Moves

In the past week, Williams Companies reported second-quarter 2026 results showing revenue of US$3,053 million and net income of US$827 million, with basic and diluted earnings per share from continuing operations of US$0.68, and also announced a quarterly dividend increase to US$0.525 per share, or US$2.10 annualized. Alongside higher earnings and a larger dividend, Williams advanced its Socrates Power Innovation project, completed the US$5.50 billion Momentum Midstream acquisition, and...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

Broadcom (AVGO) AI Push Keeps Valuation In Focus

Broadcom (AVGO) is back in focus after announcing new AI driven security upgrades to VMware vDefend and Avi Load Balancer, alongside strong AI semiconductor momentum tied to custom chips for large hyperscale customers. See our latest analysis for Broadcom. Broadcom's recent AI security updates and custom chip wins come after a strong run, with a year to date share price return of 21.51% and a 1 year total shareholder return of 40.01%, while the 3 year total shareholder return is over 4x. If...
NasdaqGS:CRSR
NasdaqGS:CRSRTech

AI Stocks Retail Investors Are Watching As Enterprise Software Spending Shifts

AI and tech related earnings updates are back in focus, with companies such as Applied Materials and Cisco under close watch for how much capital is now flowing into artificial intelligence infrastructure. This wave of spending interest puts stocks tied to chips, cloud and software in the spotlight. This article highlights three stocks from the Artificial Intelligence Stocks screener that sit at the heart of this shift and explains what makes each one stand out. The three companies featured...
NasdaqGS:BAND
NasdaqGS:BANDTelecom

Bandwidth (BAND) Lifted Guidance, Is The Upside Already Priced In?

Bandwidth (BAND) drew investor attention after its latest earnings report on July 29, 2026, which highlighted year-over-year revenue growth, a move from loss to profit, and higher full year revenue guidance. See our latest analysis for Bandwidth. The earnings release and raised guidance on July 29, 2026 come after a sharp recent pullback, with a 30-day share price return of a 30.17% decline. However, momentum over the longer term has been stronger, as the year-to-date share price return is...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

NovoCure (NVDA) Following TTFields Optimism And FDA Approval Hopes Looks Undervalued

Recent momentum in NovoCure (NVCR) stock has been closely tied to renewed optimism around its tumor treating fields devices and the possibility of upcoming FDA approval, which has kept investor attention firmly on the company. See our latest analysis for NovoCure. That optimism has fed into a strong short term trend for NovoCure, with a 1 day share price return of 5.61% and a 7 day share price return of 12.99%. The 1 year total shareholder return sits at 58.81%, despite a 3 year total...
NYSE:STNG
NYSE:STNGOil and Gas

Scorpio Tankers (STNG) Gains Attention As Earnings, Dividend And Buybacks Meet Fair Value Debate

Earnings, Dividend, and Buybacks Put Scorpio Tankers in Focus Scorpio Tankers (STNG) has drawn fresh attention after its second quarter 2026 update, which combined higher net income and earnings per share with a declared cash dividend and further progress on share repurchases. The company reported second quarter net income of US$387.54 million and basic earnings per share from continuing operations of US$8.47. For the first half of 2026, net income reached US$603.8 million, with basic...
NasdaqGS:BANF
NasdaqGS:BANFBanks

BancFirst (BANF) Faces A Valuation Test As Short Term Momentum Softens

BancFirst stock performance snapshot BancFirst (BANF) has attracted attention after a period of mixed share performance, with the stock down about 1.5% over the past month but up roughly 2.1% over the past 3 months. For longer term holders, BancFirst shows a year to date gain of about 5.5%, while the 1 year total return is down roughly 5.3%. Over 3 years and 5 years, total returns are about 21.4% and 112.0% respectively. See our latest analysis for BancFirst. At a share price of $112.29,...
NYSE:STAG
NYSE:STAGIndustrial REITs

How Investors May Respond To STAG Industrial (STAG) EPS Uptick And Affirmed Dividend Amid Softer H1

STAG Industrial, Inc. reported past second-quarter 2026 results showing sales of US$223.53 million and net income of US$52.92 million, alongside affirming a third-quarter cash dividend of US$0.3875 per share. While quarterly earnings per share edged up year over year, net income for the first half of 2026 trailed the prior year, highlighting a contrast between recent momentum and earlier-period pressure. With quarterly earnings per share improving and the dividend affirmed, we’ll now examine...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

Revolution Medicines (RVMD) BeOne Deal Puts Its Valuation Back In Focus

Revolution Medicines (RVMD) drew fresh attention on 10 August 2026 after announcing a multi-part collaboration with BeOne Medicines. The agreement combines joint clinical development and regional rights for key RAS(ON) oncology assets. See our latest analysis for Revolution Medicines. The collaboration news comes after a strong period for Revolution Medicines’ share price, with a 42.03% 90-day share price return and an even larger 1-year total shareholder return that indicates strong momentum...
NYSE:COHR
NYSE:COHRElectronic

Intel Stock Drop Puts 3 AI Infrastructure Shares On Retail Investors Radar

Intel’s US$15b stock offering has pushed fresh attention onto capital intensive growth, where huge spending on factories, chips, and infrastructure can reshape future earnings power. A 4% pre market drop in Intel shares has some investors worried, while others see potential openings across related large cap stocks. This article walks through 3 companies that sit in the crosshairs of this AI driven capex story. The three stocks covered below are just a starting sample, since the full US...
NYSE:TDS
NYSE:TDSWireless Telecom

The Bull Case For Telephone and Data Systems (TDS) Could Change Following Q2 Earnings Surge And Higher Fiber Targets - Learn Why

In the past week, Telephone and Data Systems, Inc. reported Q2 2026 results showing revenue of US$309.28 million and net income of US$298.37 million, alongside a swing from a per-share loss to earnings of over US$2.40 on a diluted basis. Management also reported strong progress in fiber build-out and raised 2026 fiber address delivery guidance, even as legacy copper and cable services weighed on telecom revenue expectations. Now we’ll examine how this earnings surge, alongside upgraded fiber...
NYSE:TRIN
NYSE:TRINCapital Markets

Is Trinity Capital (TRIN) Overvalued As Revenue Rises But EPS Falls?

Why Trinity Capital Earnings Matter For Shareholders Trinity Capital (TRIN) just reported second quarter 2026 results that showed higher revenue and net income than a year ago, while earnings per share from continuing operations moved in the opposite direction. The company posted second quarter revenue of US$87.17 million and net income of US$44.41 million, compared with US$69.48 million and US$41.41 million in the prior year period. Basic and diluted EPS from continuing operations were...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Bruker (BRKR) Could Be 6% Undervalued After Quarterly Loss And 2026 Guidance

Why Bruker stock is back in focus after the latest quarterly update Bruker (BRKR) is back on investors’ radar after second quarter results combined rising sales with a reported net loss driven largely by impairment charges. Fresh 2026 revenue guidance added another key data point for the stock. See our latest analysis for Bruker. Bruker’s latest guidance for 2026, combined with the second quarter impairment charges, has come alongside a 25.91% 90 day share price return and an 83.88% 1 year...
NasdaqGS:PWP
NasdaqGS:PWPCapital Markets

Perella Weinberg Partners (PWP) Beat Expectations, Is The Premium Valuation Already Priced In?

How the latest earnings event shapes the Perella Weinberg Partners story Perella Weinberg Partners (PWP) just reported second quarter 2026 earnings that came in ahead of analyst expectations, with management pointing to a surge in announced transactions and increased client activity across key sectors. Alongside the earnings release, the company confirmed a quarterly dividend and detailed a series of partner promotions. These moves provide several concrete data points to consider when...
NYSE:AORT
NYSE:AORTMedical Equipment

Artivion (AORT) Revenue Rose As Losses Emerged, Is It Still 37% Below Fair Value?

Key earnings details from Artivion’s latest quarter Artivion (AORT) released second quarter and first half 2026 results that paired higher revenue with a move to loss making performance. This mix of growth and red ink is central to the current stock debate. See our latest analysis for Artivion. Artivion’s latest earnings release and upcoming conference appearance arrive after a mixed period, with the share price falling year to date but three year total shareholder return still positive. This...
NasdaqGS:IRTC
NasdaqGS:IRTCMedical Equipment

Should iRhythm’s Stronger Q2 2026 Results and Higher Guidance Amid Class Action Settlement Require Action From iRhythm Holdings (IRTC) Investors?

In August 2026, iRhythm Holdings reported second-quarter 2026 results showing sales rising to US$224.17 million and net loss narrowing to US$0.381 million, while also increasing full-year 2026 revenue guidance to a range of US$880 million to US$890 million. At the same time, a proposed US$45.00 million securities class action settlement related to alleged misstatements about the Zio AT device moved toward court approval, highlighting how legal outcomes and improving financial performance are...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

How Investors Are Reacting To Arrowhead Pharmaceuticals (ARWR) Soaring Sales But Deepening Losses

Arrowhead Pharmaceuticals, Inc. reported its third-quarter 2026 results, with sales rising to US$75.25 million from US$27.77 million a year earlier, while net loss widened to US$194.28 million and loss per share increased to US$1.36 from US$1.26. Over the first nine months of 2026, Arrowhead shifted from net income of US$22.12 million a year ago to a net loss of US$296.21 million despite generating more than US$400 million in sales, highlighting how rising expenses and reduced collaboration...
NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

Why Qorvo (QRVO) Is Up 8.4% After EPS Jumps On Lower Sales And Buybacks – And What's Next

In late July 2026, Qorvo reported first-quarter fiscal 2027 results showing sales of US$784.8 million versus US$818.78 million a year earlier, with net income rising to US$85.8 million from US$25.59 million and diluted EPS increasing to US$0.96 from US$0.27. Despite reporting lower revenue and completing a share repurchase of 17,597,000 shares for US$1.58 billion since November 2022, Qorvo significantly increased profitability year over year, highlighting a shift toward more efficient...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

Why VEON (VEON) Is Up 5.2% After Raising 2026 Revenue Guidance Despite Weaker Q2 Earnings

In July 2026, VEON Ltd. reported its second-quarter 2026 results, with sales rising to US$1,271 million from US$1,087 million a year earlier, while net income fell to US$122 million from US$595 million and basic earnings per share from continuing operations dropped to US$1.75 from US$8.5. At the same time, VEON raised its full-year 2026 revenue growth guidance to a 15% to 18% year-over-year increase, up from its prior 11% to 14% range, signaling greater confidence in its top-line outlook...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

Crocs (CROX) Returned To Profit And Raised Guidance, Is The Upside Already Priced In?

What Crocs’ latest results and guidance tell you as a shareholder Crocs (CROX) has drawn fresh attention after Q2 2026 results showed a move from a large prior year loss to profit, upgraded full year guidance, and sizeable ongoing share repurchases. See our latest analysis for Crocs. Crocs’ strong Q2 2026 profit, higher full year guidance, and ongoing buybacks appear to have supported momentum, with a 90 day share price return of 39.14% and a 1 year total shareholder return of 80.50%, while...
NYSE:MET
NYSE:METInsurance

Dividend Stocks Back In Focus After The Jobs Report

A softer U.S. jobs report and the prospect of steady interest rates through December have shifted the spotlight back onto dividend stocks. Income focused investors now face a mix of potential support for risk assets and fresh uncertainty around how the Federal Reserve communicates its next moves. This article walks through 3 dividend stocks from our screener that appear positively exposed to this news and explains what this could mean for your portfolio decisions. The three stocks covered...
NYSE:PB
NYSE:PBBanks

Is Prosperity Bancshares (PB) Cheap Following Strong Q2 Earnings?

Prosperity Bancshares (PB) recently reported second quarter 2026 results that included higher net interest income and net income compared with a year earlier. The update also showed lower net charge-offs and progress on loan resolution activity. See our latest analysis for Prosperity Bancshares. Prosperity Bancshares' latest earnings, lower net charge-offs and ongoing acquisition activity sit against a share price of $73.34, with a 90 day share price return of 8.23% and a 1 year total...